New Delhi: The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in ...
Read moreDetailsNew Delhi: Adar Poonawalla, CEO and Owner of Serum Institute of India (SII) is putting $250 million of his family's ...
Read moreDetailsMumbai: Dampening hopes of a COVID-19 vaccine by year-end, Serum Institute of India’s (SII) chief executive Adar Poonawalla has said ...
Read moreDetailsNew York: Reliance Jio Board Directors Isha Ambani and Akash Ambani are among the ‘emerging leaders’ from across the world. ...
Read moreDetailsPune: "More than enough" doses of the COVID-19 vaccine developed by Oxford University and AstraZeneca will be reserved for the ...
Read moreDetailsNew Delhi: Serum Institute of India (SII) has partnered with ‘AstraZeneca’ for manufacturing the Oxford vaccine candidate for COVID-19. Serum ...
Read moreDetails
By Aakar Patel As a democratic society, it is expected that India’s authorities follow the rule of law. This includes...
Read moreDetails
By Dilip Cherian Three hours is barely enough time for a working lunch in New Delhi. Yet when UAE President...
Read moreDetails
Invariably US President Donald Trump says one thing and means something completely different has, by now, become clear to the...
Read moreDetails
We are aware how, once the month of January gets over, the rest of the year flies past in the...
Read moreDetails
